Table 1 General characteristics of RCC patients
Characteristics | Value |
|---|---|
No. of patients | 174 |
Age (ys) | |
 median | 58 |
 range | 16–81 |
Gender n (%) | |
 Male | 114 (65.5) |
 Female | 60 (34.5) |
Blood glucose (mmol/L) | 6.0 (5.5–6.7) |
BMI (kg/m2) | 24.88 ± 3.55 |
Symptoms n (%) | |
 Presence | 105 (60.3) |
 Absence | 69 (39.7) |
Pathological T stage n (%) | |
 T1 | 56 (32.2) |
 T2 | 17 (9.8) |
 T3 | 95 (54.6) |
 T4 | 6 (3.4) |
Histological subtype n (%) | |
 ccRCC | 137 (78.7) |
 Papillary RCC | 17 (9.8) |
 Clear-cell papillary RCC | 6 (3.4) |
 Chromophobe RCC | 4 (2.3) |
 Xp11.2 translocation/TFE3 gene fusion RCC | 4 (2.3) |
 Succinate dehydrogenase-deficiency RCC | 2 (1.1) |
 Others | 4 (2.3) |
WHO/ISUP grade n (%) | |
 G1 | 14 (8.0) |
 G2 | 59 (33.9) |
 G3 | 74 (42.5) |
 G4 | 23 (13.2) |
 Chromophobe cell RCC not available for WHO/ISUP grade | 4 (2.3) |
Primary tumor size (cm) | 7.3 (5.0–9.5) |
Distal metastasis n (%) | |
 Presence | 46 (26.4) |
 Absence | 128 (73.6) |